Quanterix Corp
NASDAQ:QTRX

Watchlist Manager
Quanterix Corp Logo
Quanterix Corp
NASDAQ:QTRX
Watchlist
Price: 11.75 USD 0.26% Market Closed
Market Cap: 451m USD
Have any thoughts about
Quanterix Corp?
Write Note

Quanterix Corp
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Quanterix Corp
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Quanterix Corp
NASDAQ:QTRX
Other Long-Term Assets
$5m
CAGR 3-Years
40%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Other Long-Term Assets
$4.2B
CAGR 3-Years
12%
CAGR 5-Years
28%
CAGR 10-Years
18%
Danaher Corp
NYSE:DHR
Other Long-Term Assets
$2.5B
CAGR 3-Years
0%
CAGR 5-Years
26%
CAGR 10-Years
8%
Mettler-Toledo International Inc
NYSE:MTD
Other Long-Term Assets
$396.2m
CAGR 3-Years
17%
CAGR 5-Years
27%
CAGR 10-Years
9%
Agilent Technologies Inc
NYSE:A
Other Long-Term Assets
$573m
CAGR 3-Years
1%
CAGR 5-Years
-1%
CAGR 10-Years
2%
IQVIA Holdings Inc
NYSE:IQV
Other Long-Term Assets
$631m
CAGR 3-Years
7%
CAGR 5-Years
13%
CAGR 10-Years
15%
No Stocks Found

Quanterix Corp
Glance View

Market Cap
451.2m USD
Industry
Life Sciences Tools & Services

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The company is headquartered in Billerica, Massachusetts and currently employs 460 full-time employees. The company went IPO on 2017-12-07. The firm is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to reliably detect protein biomarkers at extremely low concentrations in blood, serum and other fluids. Its products include HD-X Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, and 2470 Arrayer. The company also supplies NF-Light antibodies and ELISA kits, which offer solutions for the detection of neurofilament light (Nf-L) for the development of therapeutics and diagnostics for neurodegenerative conditions. Its portfolio of available kits spans multiple therapeutic areas, including cardiology, infectious disease, inflammation, neurology, and oncology. The company provides services through its Simoa Accelerator Laboratory.

QTRX Intrinsic Value
16.88 USD
Undervaluation 30%
Intrinsic Value
Price

See Also

What is Quanterix Corp's Other Long-Term Assets?
Other Long-Term Assets
5m USD

Based on the financial report for Jun 30, 2024, Quanterix Corp's Other Long-Term Assets amounts to 5m USD.

What is Quanterix Corp's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
25%

Over the last year, the Other Long-Term Assets growth was 0%. The average annual Other Long-Term Assets growth rates for Quanterix Corp have been 40% over the past three years , 25% over the past five years .

Back to Top